From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast- is this ex Jim Mellon stock the biggest joke valuation going?

By Tom Winnifrith | Sunday 22 July 2018


Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Ok, I am back from a 22-24 mile walk which I shall write up tomorrow but if you could smell my feet? I know many of you hav e donated to Woodlarks ahead of next Saturday's 32 mile stroll by myself, Brokerman Dan and Lucian Miers and we have now raised £14,267.88 but to those who have not donated, PLEASE DO SO NOW HERE. In today's podcast I discuss the CBI talking Brexit shite again - it does NOT speak for British industry. I remind you we have no house view, ref Sosandar (SOS). I raise two questions arising out of a Saturday lunch Joshua and I had with Highland Natural Resources (HNR), notably who will back my new goat lending business. And I look at an ex Mellon stock, Okyo Pharma (OKYO), its valuation is a 100% rum and coke and I explain why.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:46:42